GT
NOVT icon

Glenmede Trust’s Novanta NOVT Stock Holding History

Glenmede Trust’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
10,551
-76
-0.7% -$9.97K 0.01% 671
2025
Q4 		$1.26M Buy
+10,627
New +$1.21M 0.01% 664
2025
Q1 		$1.23M Sell
9,630
-23
-0.2% -$3.31K 0.01% 649
2024
Q4 		$1.47M Buy
9,653
+309
+3% +$52.3K 0.01% 609
2024
Q3 		$1.67M Buy
9,344
+46
+0.5% +$8K 0.01% 607
2024
Q2 		$1.52M Buy
9,298
+686
+8% +$111K 0.01% 614
2024
Q1 		$1.51M Buy
8,612
+596
+7% +$97.8K 0.01% 625
2023
Q4 		$1.35M Sell
8,016
-1,266
-14% -$185K 0.01% 629
2023
Q3 		$1.33M Sell
9,282
-734
-7% -$120K 0.01% 599
2023
Q2 		$1.59M Hold
10,016
– – 0.01% 558
2023
Q1 		$1.59M Sell
10,016
-295
-3% -$45.3K 0.01% 559
2022
Q4 		$1.4M Sell
10,311
-1,060
-9% -$148K 0.01% 587
2022
Q3 		$1.31M Buy
11,371
+967
+9% +$132K 0.01% 586
2022
Q2 		$1.26M Buy
10,404
+3,279
+46% +$412K 0.01% 616
2022
Q1 		$1.01M Buy
7,125
+2,020
+40% +$287K 0.01% 711
2021
Q4 		$900K Buy
5,105
+70
+1% +$11.7K ﹤0.01% 772
2021
Q3 		$777K Sell
5,035
-40
-0.8% -$5.82K ﹤0.01% 773
2021
Q2 		$683K Sell
5,075
-133
-3% -$17.9K ﹤0.01% 795
2021
Q1 		$686K Buy
5,208
+123
+2% +$16.2K ﹤0.01% 757
2020
Q4 		$601K Buy
5,085
+229
+5% +$26.7K ﹤0.01% 803
2020
Q3 		$511K Buy
4,856
+691
+17% +$73K ﹤0.01% 779
2020
Q2 		$444K Buy
4,165
+2,370
+132% +$220K ﹤0.01% 799
2020
Q1 		$158K Hold
1,795
– – ﹤0.01% 1272
2019
Q4 		$158K Buy
1,795
+275
+18% +$23.7K ﹤0.01% 1272
2019
Q3 		$124 Sell
1,520
-2,815
-65% -$229K ﹤0.01% 1326
2019
Q2 		$408 Buy
4,335
+1,500
+53% +$128K ﹤0.01% 959
2019
Q1 		$239 Buy
2,835
+305
+12% +$22.9K ﹤0.01% 1114
2018
Q4 		$158 Sell
2,530
-780
-24% -$50.3K ﹤0.01% 1197
2018
Q3 		$225K Buy
3,310
+535
+19% +$37.5K ﹤0.01% 1103
2018
Q2 		$173K Buy
+2,775
New +$170K ﹤0.01% 1101

Other funds holding NOVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Glenmede Trust's NOVT Position: Q1 2026 in Review

Glenmede Trust reduced its Novanta (NOVT) stake by 0.72% in Q1 2026, selling an estimated $9.97K and leaving 10,551 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #671.

Glenmede Trust first reported a position in NOVT in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.67M in Q3 2024. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Glenmede Trust held 10,551 shares of Novanta worth $1.25M as of Q1 2026.
  • Glenmede Trust sold 76 Novanta shares in Q1 2026, an estimated $9.97K.
  • Novanta made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #671 holding.
  • Glenmede Trust first reported a position in Novanta in Q2 2018 and has held it in 30 quarters since.
  • Glenmede Trust's Novanta position peaked at $1.67M in Q3 2024.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.